1. 219O Safety and preliminary efficacy of nivolumab in patients with advanced hepatocellular carcinoma: interim analysis of the phase 1/2 CheckMate-040 study. (20th December 2016) Authors: Melero, I.; Sangro, B.; Yau, T.; Hsu, C.; Kudo, M.; Crocenzi, T.; Kim, T-Y.; Choo, S.P.; Trojan, J.; Meyer, T.; Welling, T.H.; Yeo, W.; Chopra, A.; Anderson, J.; Dela Cruz, C.; Lang, L.; Neely, J.; El-Khoueiry, A. Journal: Annals of oncology Issue: Volume 27(2016:Sep.)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 36LBA Pathological response to neoadjuvant 5-FU, oxaliplatin and docetaxel (FLOT) versus epirubicin, cisplatin and 5-FU (ECF) in patients with locally advanced, resectable gastric/esophagogastric junction (EGJ) cancer: Data from the phase II part of the FLOT4 phase III study of the AIO. Issue 3 (September 2015) Authors: Pauligk, C.; Tannapfel, A.; Meiler, J.; Luley, K.B.; Kopp, H.G.; Homann, N.; Hofheinz, R.D.; Schmalenberg, H.; Probst, S.; Haag, G.M.; Egger, M.; Behringer, D.M.; Stoehlmacher, J.; Prasnikar, N.; Block, A.; Trojan, J.; Folprecht, G.; Pohl, M.; Schirmacher, P.; Al-Batran, S.E. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Commentary: vitamin D deficiency and liver cancer – cause, effect or myth? Authors' reply. Issue 12 (June 2014) Authors: Finkelmeier, F.; Kronenberger, B.; Köberle, V.; Bojunga, J.; Zeuzem, S.; Trojan, J.; Piiper, A.; Waidmann, O. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 12(2014) Page Start: 1429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma. (December 2016) Authors: Hauck, S.; Khageh Hosseini, S.; Wesely, J.; Trojan, J.; Gerlach, K.; Schulze, J.; Hahn, S.; Steinhilber, D.; Gatterdam, V.; Zeuzem, S.; Waidmann, O.; Zangos, S.; Biondi, R.; Proschak, E.; Zörnig, M. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Severe 25‐hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma – a prospective cohort study. Issue 10 (29th March 2014) Authors: Finkelmeier, F.; Kronenberger, B.; Köberle, V.; Bojunga, J.; Zeuzem, S.; Trojan, J.; Piiper, A.; Waidmann, O. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 10(2014) Page Start: 1204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Visually induced analgesia during massage treatment in chronic back pain patients. (22nd June 2017) Authors: Löffler, A.; Trojan, J.; Zieglgänsberger, W.; Diers, M. Journal: European journal of pain Issue: Volume 21:Number 10(2017) Page Start: 1623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Watching your pain site reduces pain intensity in chronic back pain patients. (18th August 2015) Authors: Diers, M.; Löffler, A.; Zieglgänsberger, W.; Trojan, J. Journal: European journal of pain Issue: Volume 20:Number 4(2016) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗